Browsing by Author "Oaknin, Ana"
Now showing items 1-3 of 3
-
Trial in Progress of Engot-Cx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin +/- Bevacizumab in Recurrent/Metastatic Cervical Cancer
Vergote, Ignace; Mirza, Mansoor; Sehouli, Jalid; Lorusso, Domenica; Kose, Fatih; Cibula, David; Westermann, Anneke; Collins, Dearbhaile; Banerjee, Susana; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, Bradley (2022) -
Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: Addition of a new cohort with first-line (1L) tisotumab vedotin (TV) plus pembrolizumab (pembro) plus carboplatin (carbo) +/- bevacizumab (bev) in recurrent/metastatic cervical cancer (r/mCC)
Vergote, Ignace; Mirza, Mansoor Raza; Sehouli, Jalid; Lorusso, Domenica; Ose, Fatih K.; Cibula, David; Westermann, Anneke M.; Collins, Dearbhaile Catherine; Banerjee, Susana N.; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, Bradley J. (2022) -
Trial in Progress Update on Engotcx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin - Bevacizumab in Recurrentimetastatic Cervical Cancer
Vergote, Ignace; Mirza, Mansoor; Sehouli, Jalid; Lorusso, Domenico; Kose, Fatih; Cibula, David; Westermann, Anneke; Collins, Dearbhaile; Banerjee, Susana; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, Bradley J. (2022)
